These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

219 related items for PubMed ID: 21046311

  • 1. p53 abnormality and tumor invasion in patients with malignant astrocytoma.
    Momota H, Narita Y, Matsushita Y, Miyakita Y, Shibui S.
    Brain Tumor Pathol; 2010 Oct; 27(2):95-101. PubMed ID: 21046311
    [Abstract] [Full Text] [Related]

  • 2. Incidence and timing of p53 mutations during astrocytoma progression in patients with multiple biopsies.
    Watanabe K, Sato K, Biernat W, Tachibana O, von Ammon K, Ogata N, Yonekawa Y, Kleihues P, Ohgaki H.
    Clin Cancer Res; 1997 Apr; 3(4):523-30. PubMed ID: 9815715
    [Abstract] [Full Text] [Related]

  • 3. High frequency of p53 protein accumulation without p53 gene mutation in human juvenile pilocytic, low grade and anaplastic astrocytomas.
    Lang FF, Miller DC, Pisharody S, Koslow M, Newcomb EW.
    Oncogene; 1994 Mar; 9(3):949-54. PubMed ID: 8108140
    [Abstract] [Full Text] [Related]

  • 4. Ethnicity delineates different genetic pathways in malignant glioma.
    Chen P, Aldape K, Wiencke JK, Kelsey KT, Miike R, Davis RL, Liu J, Kesler-Diaz A, Takahashi M, Wrensch M.
    Cancer Res; 2001 May 15; 61(10):3949-54. PubMed ID: 11358811
    [Abstract] [Full Text] [Related]

  • 5. Assessment of 1p/19q status by fluorescence in situ hybridization assay: A comparative study in oligodendroglial, mixed oligoastrocytic and astrocytic tumors.
    Shukla B, Agarwal S, Suri V, Pathak P, Sharma MC, Gupta D, Sharma BS, Suri A, Halder A, Sarkar C.
    Neurol India; 2009 May 15; 57(5):559-66. PubMed ID: 19934553
    [Abstract] [Full Text] [Related]

  • 6. Prognostic impact of TP53 mutation status for adult patients with supratentorial World Health Organization Grade II astrocytoma or oligoastrocytoma: a long-term analysis.
    Ständer M, Peraud A, Leroch B, Kreth FW.
    Cancer; 2004 Sep 01; 101(5):1028-35. PubMed ID: 15329912
    [Abstract] [Full Text] [Related]

  • 7. Prognostic impact of TP53 mutations and P53 protein overexpression in supratentorial WHO grade II astrocytomas and oligoastrocytomas.
    Peraud A, Kreth FW, Wiestler OD, Kleihues P, Reulen HJ.
    Clin Cancer Res; 2002 May 01; 8(5):1117-24. PubMed ID: 12006527
    [Abstract] [Full Text] [Related]

  • 8. Expression of tenascin-C in various human brain tumors and its relevance for survival in patients with astrocytoma.
    Leins A, Riva P, Lindstedt R, Davidoff MS, Mehraein P, Weis S.
    Cancer; 2003 Dec 01; 98(11):2430-9. PubMed ID: 14635078
    [Abstract] [Full Text] [Related]

  • 9. Molecular genetic analysis of p53 intratumoral heterogeneity in human astrocytic brain tumors.
    Ren ZP, Olofsson T, Qu M, Hesselager G, Soussi T, Kalimo H, Smits A, Nistér M.
    J Neuropathol Exp Neurol; 2007 Oct 01; 66(10):944-54. PubMed ID: 17917588
    [Abstract] [Full Text] [Related]

  • 10. Reappraisal of p53 mutations in human malignant astrocytic neoplasms by p53 functional assay: comparison with conventional structural analyses.
    Tada M, Iggo RD, Waridel F, Nozaki M, Matsumoto R, Sawamura Y, Shinohe Y, Ikeda J, Abe H.
    Mol Carcinog; 1997 Mar 01; 18(3):171-6. PubMed ID: 9115587
    [Abstract] [Full Text] [Related]

  • 11. Adult grade II diffuse astrocytomas are genetically distinct from and more aggressive than their paediatric counterparts.
    Jones DT, Mulholland SA, Pearson DM, Malley DS, Openshaw SW, Lambert SR, Liu L, Bäcklund LM, Ichimura K, Collins VP.
    Acta Neuropathol; 2011 Jun 01; 121(6):753-61. PubMed ID: 21327941
    [Abstract] [Full Text] [Related]

  • 12. Role of gemistocytes in astrocytoma progression.
    Watanabe K, Tachibana O, Yonekawa Y, Kleihues P, Ohgaki H.
    Lab Invest; 1997 Feb 01; 76(2):277-84. PubMed ID: 9042164
    [Abstract] [Full Text] [Related]

  • 13. Heterozygosity status of 1p and 19q and its correlation with p53 protein expression and EGFR amplification in patients with astrocytic tumors: novel series from India.
    Jha P, Agarwal S, Pathak P, Srivastava A, Suri V, Sharma MC, Chosdol K, Srivastava T, Gupta D, Gupta A, Suri A, Sarkar C.
    Cancer Genet Cytogenet; 2010 Apr 15; 198(2):126-34. PubMed ID: 20362227
    [Abstract] [Full Text] [Related]

  • 14. p53 mutation and loss of heterozygosity on chromosomes 17 and 10 during human astrocytoma progression.
    Fults D, Brockmeyer D, Tullous MW, Pedone CA, Cawthon RM.
    Cancer Res; 1992 Feb 01; 52(3):674-9. PubMed ID: 1346255
    [Abstract] [Full Text] [Related]

  • 15. TP53 mutations in malignant astrocytomas.
    Biernat W, Debiec-Rychter M, Kordek R, Liberski PP.
    Pol J Pathol; 1997 Feb 01; 48(4):221-4. PubMed ID: 9529927
    [Abstract] [Full Text] [Related]

  • 16. Detection of IDH1 mutations in gliomatosis cerebri, but only in tumors with additional solid component: evidence for molecular subtypes.
    Seiz M, Tuettenberg J, Meyer J, Essig M, Schmieder K, Mawrin C, von Deimling A, Hartmann C.
    Acta Neuropathol; 2010 Aug 01; 120(2):261-7. PubMed ID: 20514489
    [Abstract] [Full Text] [Related]

  • 17. Alterations of the TP53 gene in human gliomas.
    Rasheed BK, McLendon RE, Herndon JE, Friedman HS, Friedman AH, Bigner DD, Bigner SH.
    Cancer Res; 1994 Mar 01; 54(5):1324-30. PubMed ID: 8118823
    [Abstract] [Full Text] [Related]

  • 18. [An immunohistochemical study of the expression of the oncoprotein p53 in astrocytic gliomas of the cerebral hemispheres].
    Korshunov AG, Sycheva RV.
    Arkh Patol; 1996 Mar 01; 58(6):37-42. PubMed ID: 9139592
    [Abstract] [Full Text] [Related]

  • 19. Telomerase activity and alterations in telomere length in human brain tumors.
    Hiraga S, Ohnishi T, Izumoto S, Miyahara E, Kanemura Y, Matsumura H, Arita N.
    Cancer Res; 1998 May 15; 58(10):2117-25. PubMed ID: 9605755
    [Abstract] [Full Text] [Related]

  • 20. Expression and mutation analysis of the p53 gene in astrocytoma.
    Hwang SL, Hong YR, Sy WD, Chai CY, Lin HJ, Howng SL.
    J Formos Med Assoc; 1999 Jan 15; 98(1):31-8. PubMed ID: 10063271
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.